However, other precipitants of AKI could be associated with a potentially beneficial impact of SGLT2 inhibition (such as reduced CKD, heart failure and hyperglycaemia) or a potentially detrimental impact (such as hypovolaemia or ketoacidosis) (Fig. 3). Here, SLC5A2 is linked to acute kidney injury.